Clinical Trial RESULTS
Clinical Trial
RESULTS
Research Sponsor: Ardea Biosciences, Inc.
Drug Studied: Lesinurad/Allopurinol Fixed Dose Combination
Study Drug Indication: Gout
National Clinical Trial #: NCT02581553
Protocol #: RDEA594-501
Study Date: October 2015 to July 2016
Short Study Title: A study to measure and compare healthy adultsâ€™ blood
levels of lesinurad and allopurinol, taken in a combined
tablet and separate tablets, both with and without food
Thank you!
As a clinical study participant, you belong to a large community of participants around
the world. You help researchers answer important health questions and discover new
medical treatments.
Thank you for taking part in the clinical study for the drugs lesinurad and allopurinol.
These drugs have been developed to treat gout, a type of arthritis.
You and all of the other participants helped researchers learn how lesinurad and allopurinol
acted in the body when given as 1 combined tablet and as 2 separate tablets.
Ardea Biosciences, Inc., the sponsor of this study, thanks you for your help and thinks
it is important for you to know the results of your study. An independent non-profit
organization called CISCRP prepared this summary of the study results for you with the
help of a medical writing organization. We hope it helps you understand and feel proud
of your important role in medical research. If you have questions about the results, please
speak with the doctor or staff at your study site.
11